IMC Chicago
NVO

IMC Chicago’s Novo Nordisk NVO Stock Holding History

IMC Chicago’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.1M Buy
1,854,400
+385,700
+26% +$18.3M 0.02% 403
2025
Q4 		$74.7M Sell
1,468,700
-1,420,700
-49% -$72.6M 0.03% 367
2025
Q3 		$160M Buy
2,889,400
+1,891,600
+190% +$111M 0.06% 185
2025
Q2 		$68.9M Buy
997,800
+178,700
+22% +$12.2M 0.03% 316
2025
Q1 		$56.9M Buy
819,100
+206,300
+34% +$17M 0.03% 291
2024
Q4 		$52.7M Buy
612,800
+73,400
+14% +$7.94M 0.02% 329
2024
Q3 		$64.2M Buy
539,400
+52,000
+11% +$6.93M 0.03% 253
2024
Q2 		$69.6M Buy
487,400
+38,700
+9% +$5.13M 0.04% 222
2024
Q1 		$57.6M Buy
448,700
+181,600
+68% +$21.6M 0.04% 222
2023
Q4 		$27.6M Buy
267,100
+149,100
+126% +$14.7M 0.02% 380
2023
Q3 		$10.7M Buy
+118,000
New +$10.4M 0.01% 541

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

IMC Chicago's NVO Position: Q1 2026 in Review

IMC Chicago increased its Novo Nordisk (NVO) stake by 648% in Q1 2026, buying an estimated $32.9M and bringing the position to 802,198 shares worth $29.5M. The position accounts for 0.01% of the portfolio, ranked #693.

IMC Chicago first reported a position in NVO in Q3 2024 and has held it in 7 quarters since. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • IMC Chicago held 802,198 shares of Novo Nordisk worth $29.5M as of Q1 2026.
  • IMC Chicago bought 694,983 Novo Nordisk shares in Q1 2026, an estimated $32.9M.
  • Novo Nordisk made up 0.01% of IMC Chicago's portfolio in Q1 2026, its #693 holding.
  • IMC Chicago first reported a position in Novo Nordisk in Q3 2024 and has held it in 7 quarters since.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.